Abstract
Hand-foot syndrome, or palmar plantar erythrodysesthesia, is a chemotherapy-induced cutaneous reaction typically characterized by painful erythema of the palms and soles followed by desquamation and exfoliation in those areas. This report represents the first case of hand-foot syndrome associated with penile erythema, pain, and desquamation in addition to the classic hand and sole findings.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.2165%2F00128071-200405030-00010/MediaObjects/40257_2012_5030209_Fig1.jpg)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.2165%2F00128071-200405030-00010/MediaObjects/40257_2012_5030209_Fig2.jpg)
Similar content being viewed by others
References
Nagore E, Insa A, Sanmartin O. Antineoplastic therapy-induced palmar plantar erythrodysesthesia (‘hand-foot’) syndrome: incidence, recognition and management. Am J Clin Dermatol 2000 Jul-Aug; 1 (4): 225–34
Baer MR, King LE, Wolff SN. Palmar-plantar erythrodysesthesia and cytarabine [letter]. Ann Intern Med 1985 Apr; 102 (4): 556
Herzig RH, Wolff SN, Lazarus HM, et al. High-dose cytosine arabinoside therapy for refractory leukemia. Blood 1983; 62: 361–9
Hines JD, Zakem MH, Adelstein TJ, et al. Treatment of advanced stage colorectal adenocarcinoma with fluorouracil and high-dose leucovorin calcium: a pilot study. J Clin Oncol 1988; 6: 142–6
Hoff PM, Valero V, Ibrahim N, et al. Hand-foot syndrome following prolonged infusion of high doses of vinorelbine. Cancer 1998 Mar 1; 82 (5): 956–9
Ikeda H, Kawano H, Kitaura T, et al. Acral erythema associated with high-dose methotrexate infusion [case report]. Ann Pharmacother 1999 May; 33 (5): 646
Jucgla A, Sais G, Navarro M, et al. Palmoplantar keratoderma secondary to chronic acral erythema due to tegafur. Arch Dermatol 1995 Mar; 131 (3): 364–5
Kampmann KK, Graves T, Rogers SD. Acral erythema secondary to high-dose cytosine arabinoside with pain worsened by cyclosporine infusions. Cancer 1989 Jun 15; 63 (12): 2482–5
Koletsky A, Jahanzeb M, Radice P, et al. A randomized phase II trial of pegylated liposomal doxorubicin (PG-LD) as second line treatment in non-small cell lung cancer (NSCLC) patients with prior exposure to platinum based therapy [abstract 1888]. Proc Am Soc Clin Oncol 1998; 17: 490A
Kroll SS, Koller CA, Kaled S, et al. Chemotherapy-induced acral erythema: desquamating lesions involving the hands and feet. Ann Plast Surg 1989 Sep; 23 (3): 263–5
Lokich JJ, Ahlgren JD, Gullo JJ, et al. A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a Mid-Atlantic Oncology Program study. J Clin Oncol 1989; 7: 425–32
Susser WS, Whitaker-Worth DL, Grant-Kels JM. Mucocutaneous reactions to chemotherapy. J Am Acad Dermatol 1999; 40: 367–98
Baack BR, Burgdorf WH. Chemotherapy-induced acral erythema. J Am Acad Dermatol 1991; 24 (3): 457–61
Chiara S, Nobile MT, Barzacchi C, et al. Hand-foot syndrome induced by high-dose, short-term, continuous 5-fluorouracil infusion. Eur J Cancer 1997; 33 (6): 967–9
Acknowledgments
No sources of funding were used to assist in the preparation of this report. The author has no conflicts of interest that are directly relevant to the content of this report.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sorscher, S.M. Penile Involvement with Hand-Foot Syndrome. Am J Clin Dermatol 5, 209–210 (2004). https://doi.org/10.2165/00128071-200405030-00010
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128071-200405030-00010